These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38898676)

  • 1. Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population.
    Sigurdardottir G; Alsterholm M; Andersson CD; Bradley M; Sandström Falk M; Johansson EK; Lundqvist M; Sonesson A; Svensson Å; Theodosiou G; Vrang S; Von Kobyletzki LB
    Acta Derm Venereol; 2024 Jun; 104():adv38889. PubMed ID: 38898676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Ragamin A; Zhang J; Pasmans SGMA; Schappin R; Romeijn GLE; van Reusel MA; Oosterhaven JAF; Schuttelaar MLA
    Br J Dermatol; 2024 May; 190(6):867-875. PubMed ID: 38262143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spanish Version of the RECAP Questionnaire to Assess Control of Atopic Eczema: Translation, Cultural Adaptation, Validation, and Correlations with Other Patient-Reported Outcome Measures.
    Onteniente-Gomis MM; Ortiz-Romero PL; Tous Romero F; Salamanca Castro AB; Ortiz de Frutos FJ
    Actas Dermosifiliogr; 2023 Jun; 114(6):488-493. PubMed ID: 36935038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Recap of Atopic Eczema (RECAP) Measurement Instrument for Eczema Control in Adult Patients in an Asian Clinical Setting.
    Yew YW; Phuan CZY; Zhao X; Howells L; Apfelbacher CJ
    Acta Derm Venereol; 2024 May; 104():adv32323. PubMed ID: 38738773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire.
    Zhang J; Ragamin A; Romeijn GLE; Loman L; Oosterhaven JAF; Schuttelaar MLA
    Br J Dermatol; 2023 Oct; 189(5):578-587. PubMed ID: 37463409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study.
    Gabes M; Ragamin A; Baker A; Kann G; Donhauser T; Gabes D; Howells L; Thomas KS; Oosterhaven JAF; Pasmans SGMA; Schuttelaar ML; Apfelbacher C
    Br J Dermatol; 2022 Dec; 187(6):919-926. PubMed ID: 35842231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.
    Simpson EL; Bissonnette R; Paller AS; King B; Silverberg JI; Reich K; Thyssen JP; Doll H; Sun L; DeLozier AM; Nunes FP; Eichenfield LF
    Br J Dermatol; 2022 Oct; 187(4):531-538. PubMed ID: 35442530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.
    Guttman-Yassky E; Bar J; Rothenberg-Lausell C; Eichenfield L; Grada A; Abuabara K; Chapman M; Calimlim B; Wegzyn C; Gamelli A; Krueger W; Munoz B; Knapp K; Faller R; Crawford J; Silverberg J
    J Drugs Dermatol; 2023 Apr; 22(4):344-354. PubMed ID: 37026893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
    Simpson E; Bissonnette R; Eichenfield LF; Guttman-Yassky E; King B; Silverberg JI; Beck LA; Bieber T; Reich K; Kabashima K; Seyger M; Siegfried E; Stingl G; Feldman SR; Menter A; van de Kerkhof P; Yosipovitch G; Paul C; Martel P; Dubost-Brama A; Armstrong J; Chavda R; Frey S; Joubert Y; Milutinovic M; Parneix A; Teixeira HD; Lin CY; Sun L; Klekotka P; Nickoloff B; Dutronc Y; Mallbris L; Janes JM; DeLozier AM; Nunes FP; Paller AS
    J Am Acad Dermatol; 2020 Sep; 83(3):839-846. PubMed ID: 32344071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.
    Oosterhaven JAF; Spekhorst LS; Zhang J; Voorberg AN; Romeijn GLE; Boesjes CM; de Graaf M; de Bruin-Weller MS; Schuttelaar MLA
    J Dermatolog Treat; 2022 Jun; 33(4):1986-1989. PubMed ID: 34151695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
    Howells LM; Chalmers JR; Gran S; Ahmed A; Apfelbacher C; Burton T; Howie L; Lawton S; Ridd MJ; Rogers NK; Sears AV; Spuls P; von Kobyletzki L; Thomas KS
    Br J Dermatol; 2020 Sep; 183(3):524-536. PubMed ID: 31794074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The German RECAP questionnaire: linguistic validation and cognitive debriefing in German adults with self-reported atopic eczema and parents of affected children.
    Gabes M; Tischer C; Herrmann A; Howells L; Apfelbacher C
    J Patient Rep Outcomes; 2021 Jan; 5(1):13. PubMed ID: 33475902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [JAPANESE TRANSLATION AND LINGUISTIC VALIDATION OF THE RECAP OF ATOPIC ECZEMA (RECAP)].
    Itonaga T; Yanagida N; Nishino M; Sato S; Ohmatsu H; Otake N; Makita E; Fukuie T; Miura T; Chiyotanda M; Suzuki M; Manabe T; Koike Y; Futamura M; Nagao M; Ogata M; Takayama R; Sugiyama A; Kataoka Y; Ishiuji Y; Masuda K; Tanaka A; Nakahara T; Murota H; Saeki H; Katoh N; Ebisawa M
    Arerugi; 2023; 72(10):1240-1247. PubMed ID: 38092400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement properties of the product of investigator's global assessment and body surface area in children and adults with atopic dermatitis.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):180-187. PubMed ID: 32745300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Product of Investigator Global Assessment and Body Surface Area (IGAxBSA): A practice-friendly alternative to the Eczema Area and Severity Index to assess atopic dermatitis severity in children.
    Suh TP; Ramachandran D; Patel V; Jackson KL; Rangel SM; Fishbein AB; Paller AS
    J Am Acad Dermatol; 2020 May; 82(5):1187-1194. PubMed ID: 31972257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
    J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
    Guttman-Yassky E; Teixeira HD; Simpson EL; Papp KA; Pangan AL; Blauvelt A; Thaçi D; Chu CY; Hong HC; Katoh N; Paller AS; Calimlim B; Gu Y; Hu X; Liu M; Yang Y; Liu J; Tenorio AR; Chu AD; Irvine AD
    Lancet; 2021 Jun; 397(10290):2151-2168. PubMed ID: 34023008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.